The present decade has seen a reawakening of tuberculosis (TB) drug research and development (R&D), spurred on by an urgent need to stem the tide of the disease globally and develop new ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

Multidrug resistant tuberculosis (MDR-TB) is a serious, life-threatening illness with evolving treatment regimens for better ...

Day.The World Health Organisation estimates that a quarter of the world’s population is infected with latent TB, of which 10 ...

The country is also home to 47% of people who developed multi-drug resistant infection which is unresponsive or resistant to at least two of the first line of anti-TB drugs the same year.

New Delhi: In a move that will benefit tuberculosis patients, Indian Patent Office (IPO) has denied the US giant Johnson & Johnson's request to extend its patent on the life-saving TB drug ...